Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India

BACKGROUND: The combination of whole-cell pertussis (wP) antigens with established diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and inactivated poliomyelitis (IPV) antigens provides a high-quality DTwP-IPV-HB-PRP∼T vaccine. This study evaluated a DTwP-IPV-HB-PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangarule, S, Palkar, S, Mitra, M, Ravi, MD, Singh, R, Moureau, A, Jayanth, MV, Patel, DM, Ravinuthala, S, Patnaik, BN, Jordanov, E, Noriega, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309395/
https://www.ncbi.nlm.nih.gov/pubmed/35899104
http://dx.doi.org/10.1016/j.jvacx.2022.100190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309395/
https://www.ncbi.nlm.nih.gov/pubmed/35899104
http://dx.doi.org/10.1016/j.jvacx.2022.100190

Ejemplares similares